Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension

por Ramani, Gautam V, Park, Myung H
Publicado 2010

Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study

por Benza, Raymond L., Raina, Amresh, Gupta, Himanshu, Murali, Srinivas, Burden, Annie, Zastrow, Michael S., Park, Myung H., Simon, Marc A.
Publicado 2017

Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmona...

por Han, Yuchi, Forfia, Paul R, Vaidya, Anjali, Mazurek, Jeremy A, Park, Myung H, Ramani, Gautam, Chan, Stephen Y, Waxman, Aaron B
Publicado 2018

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

por Araujo-Gutierrez, Raquel, Ibarra-Cortez, Sergio H., Estep, Jerry D., Bhimaraj, Arvind, Guha, Ashrith, Hussain, Imad, Park, Myung H., Torre-Amione, Guillermo, Trachtenberg, Barry H.
Publicado 2018

The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal Study

por Kerr, Kim M, Elliott, C Greg, Benza, Raymond L, Channick, Richard N, Chin, Kelly M, Davis, R Duane, Jain, Sonia, LaCroix, Andrea Z, Madani, Michael M, McLaughlin, Vallerie V, Park, Myung H, Tapson, Victor F, Auger, William R
Publicado 2021